Co-trimoxazole
Therapeutic agent (verify pharmacological class)
What it is used for
URTI, LRTI, UTI, GI infections, skin infections. Clinical selection for Co-trimoxazole should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Regular blood counts (on prolonged use), folate impairement, lactation, renal impairment, elderly, maintain adequate fluid output, allergic conditions, bronchial asthma, use of diuretics, concommitant use with coumarin anticoagulants, methotrexate, phenytoin.
Possible side effects
Haematological changes, skin disorders, erythema multiforme, nausea and vomiting, toxic epidermal necrolysis, allergic vasculitis, glossitis, stomatitis, transient jaundice, acidosis, goitre, hypoglycaemic effect. High dose: tinnitus and peripheral neuritis.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.